---
$id: https://graph.org.ai/products/commodity/51172313
$type: Product
source: UNSPSC
code: "51172313"
title: "Fomepizole"
class: "51172300"
classTitle: "Antidotes and emetics"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Fomepizole

**UNSPSC Code**: 51172313
**Class**: [Antidotes and emetics](Antidotes and emetics.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an enzyme inhibitor with the molecular formula C4H6N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 83LCM6L2BY, chemically known as 1h-pyrazole, 4-methyl- but generally known as fomepizole, which bears US NIH Compound Identifier 3406. European Medicines Agency schedules Fomepizole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07775MIG. The term FOMEPIZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). World Health Organization schedules fomepizole in its Anatomical Therapeutic Chemical (ATC) Classification. FOMEPIZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fomepizole under HS 29331990 and SITC 51571. As of Q4 2014, FOMEPIZOLE remains the US FDA Preferred Term for this commodity. Fomepizole bears US NLM identifiers UMLS ID C0048504 and NCI Concept Code C47538. SMILES: [NH]1NCC(C1)C.

